Abstract:Postpartum venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is a critical complication occurring in the postpartum period. The pathogenesis involves a hypercoagulable state induced by pregnancy-related physiological changes, venous stasis from reduced mobility and pelvic compression during delivery, and endothelial injury. Postpartum VTE is a leading cause of maternal morbidity and mortality, necessitating heightened clinical vigilance. Understanding the risk factors, implementing prophylactic measures, and ensuring timely intervention are paramount for improving maternal health outcomes related to venous embolic events. The presented case is a 37-year-old female with a complex medical history marked by recurrent thrombotic events and pregnancy complications. Despite various prophylactic and therapeutic interventions, her condition culminated in severe chronic venous obstruction (CVO) requiring advanced interventional treatment and stent-graft implantation. Her medical history began in 2012 with two spontaneous abortions, leading to the identification of genetic mutations, including a homozygous methylenetetrahydrofolate reductase (MTHFR) mutation. In 2016, she developed PE after receiving hormonal contraceptive therapy without antithrombotic prophylaxis. Subsequent pregnancy was closely monitored, yet she suffered severe complications, including a cesarean delivery complicated by preeclampsia and postoperative thrombocytopenia, leading to massive iliofemoral-popliteal DVT. Initial treatment with vitamin K antagonists (VKA) was replaced with apixaban following a recurrent thrombotic event. Despite optimal anticoagulation, the patient developed symptomatic inferior vena cava (IVC) syndrome in 2022, characterized by chronic IVC occlusion, acute thrombosis of the portal and inferior mesenteric veins, and extensive collateral venous networks. She underwent recanalization and stenting of the iliac veins and IVC. This was followed by a hysterectomy due to metrorrhagia, significantly improving her quality of life. In this case, the homozygous MTHFR mutation was associated with recurrent thrombotic events and pregnancy complications. Despite multiple guidelines advising against MTHFR testing for thrombosis evaluation, the patient's management was influenced by her genetic profile and clinical history. Direct oral anticoagulants (DOACs) have shown efficacy in treating VTE in patients with hereditary thrombophilia. The clinical case also highlights the complexity of anticoagulation management, particularly after venous stenting, where maintaining stent patency poses significant challenges. Venous stenting, especially in CVO, has demonstrated substantial benefits, as evidenced by the patient's marked symptom improvement post-procedure. The long-term efficacy of stenting, optimal anticoagulation strategies, and post-procedural therapy require further research. This case highlights the complexities of managing hereditary thrombophilia with recurrent thrombosis and the evolving role of venous stenting in treating CVO. Individualized anticoagulation and multidisciplinary care are essential, with further studies needed to refine treatment and improve outcomes.

Women with Complex Vascular Anomalies: Impact on Contraception, Pregnancy and Reproductive Health

Understanding Pregnancy-Related Cardiovascular Disease Risk Communication and Management Among Women Veterans

Challenges in Management of the Adult Vascular Anomalies Population: A Case Report and Review of the Literature

Management and outcomes of pregnant women with cardiovascular diseases in a cardio-obstetric team

Pregnancy and the Postpartum Period as an Opportunity for Cardiovascular Risk Identification and Management

Navigating Postpartum Venous Thromboembolism: A Case of Thrombophilia, Bleeding Complications, and Chronic Inferior Vena Cava Syndrome

Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review

Cardiovascular complications during pregnancy: Advancing cardio-obstetrics

Cardiovascular disease in menopause: Does the obstetric history have any bearing?

Sex-Related Differences and Influence of Pregnancy in Transposition of Great Arteries With Systemic Right Ventricle

Factors affecting the ability of patients with complex vascular anomalies to navigate the healthcare system

Placental Findings in Pregnancies Complicated by Maternal Cardiovascular Disease

Anticoagulant therapy in pregnant women with mechanical and bioprosthetic heart valves

Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals With Autoimmune and Rheumatic Diseases

Reproductive planning, vitamin knowledge and use, and lifestyle risks of women attending pregnancy care with a severe mental illness

Pregnancy outcomes in women with significant valve disease: a systematic review and meta-analysis

Vascular Ehlers‐Danlos syndrome and pregnancy: A systematic review

Patient acceptability, continuation and complication rates with immediate postpartum levonorgestrel intrauterine device insertion at caesarean section and vaginal birth

Factors affecting pathways to care for children and adolescents with complex vascular malformations: parental perspectives

Vascular Health of Females with History of Assisted Reproductive Technology

Dyadic coping experiences of parents of children with vascular anomalies